Clinical information: crd_992 - valved grafts pas, patient site id: (b)(6).It was reported that on (b)(6) 2023, a 27mm sjm masters series valsalva aortic valved graft was chosen for implant.The graft was successfully placed without difficulty.Post implant, the myocardial pacing leads were left in place per usual.On (b)(6) 2023, atrial fibrillation with bradycardia and atrioventricular block were detected via electrocardiogram (ecg).Amiodarone was administered as treatment.Another ecg was taken on (b)(6) 2023, and it was confirmed that the patient was in sinus rhythm.On (b)(6) 2023, the myocardial pacing leads were removed.A transthoracic echocardiogram (tte) was performed on 17 july, which showed a single pericardial effusion in the right ventricle with 17mm in the right anterior ventricle, 17mm next to the pulmonary infundibulum, and 5-6mm in the right inferior ventricle.Another tte was taken on (b)(6) 2023, and the pericardial effusion was the same size (18mm maximum) and was stable.No intervention was provided to treat the pericardial effusion.It was stated that the pericardial effusion was caused by the removal of the myocardial leads.The patient was discharged the following day on (b)(6) 2023.
|
An event of arrhythmia two days after the masters grafted valve was implanted and pericardial effusion caused by the removal of the myocardial leads was reported.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.Information from the field indicated that arrhythmia was not related to valve malfunction.The root cause of the reported event could not be conclusively determined.There is no indication of a product quality issue with regards to manufacture, design, or labeling.
|